How vulnerable are the EU institutions to undue corporate influence, and what gaps exist in EU lobbying and ethics rules?
Open letter to Commissioner Andriukaitis on glyphosate
Who are the biggest climate criminals?
One in three (9 out of 26) outgoing commissioners who left office in 2014 have gone through the 'revolving door' into roles in corporations or other organisations with links to big business, leading to fears of an unhealthily close relationship between the EU's executive body and private interests. In our view, at least eight revolving door roles, held by four commissioners, should not have received authorisation at all, due to the risk of possible conflicts of interest.
2 to 10 times more pharma lobby meetings took place below the Commission's top levels disclosed online.
A new briefing in French and English by CEO shows how Solutions COP21 in Paris, which is supposed to showcase climate solutions during COP21, is in fact just a corporate greenwashing vehicle that also enables big business to buy access to decision makers. Aimed at activists, the 4-page briefing is a what's what on (false) Solutions COP21.
Murky channels for corporate influence in the European Parliament.
New report exposes systemic collusion between big business and EU trade negotiators in pushing an aggressive market opening agenda in the public sector through CETA and TTIP, which could endanger citizens’ rights to basic services like water, health, and energy.
The car manufacturing industry is traditionally one of Brussels' strongest, and has a particularly German flavour. But the recent scandal engulfing Volkswagen (VW – who also make Audi) and potentially others shows that if Europe is serious about regulating the car industry and protecting public health and the climate, it needs to stand up to the car lobby rather than allowing those resisting regulation to write it.
Spare a thought for big business lobbyists who are apparently “less successful than citizen groups at lobbying EU legislators” according to this research.
After a decade of lobby scandals and debate on how to secure transparency and ethics, the European Commission needs to go beyond half measures.
22+23/09/15. Policy-makers want their decisions to be based on the best available evidence; controlling the relevant science is therefore a key component of the strategy of the lobbyists who can afford it. During two days, this conference will analyse evidence politics and discuss evidence policies to find out how to make the existing EU scientific evidence appraisal system evolve towards better serving the public interest.
We are a small team that works fully independently of funding from the EU,
governments, political parties and corporations.
Every single donation helps us fight the hold of Big Business over the EU.